Quantcast

Latest Pharmaceutical drug Stories

2014-09-02 23:03:28

REMIND-A-CAP™ will help the 50% of Americans who do not follow their physician's orders when taking prescription medicine while reducing some of the $290 billion spent each year in avoidable medical expenses attributed to non-adherence New York, NY (PRWEB) September 02, 2014 A New York City based company is focused on addressing the non-adherence epidemic with a simple, yet revolutionary, product that will have far-reaching, positive effects including increasing life span and...

2014-09-02 08:28:22

ALBANY, New York, September 2, 2014 /PRNewswire/ -- According to a new market report published "Biological Drugs Market [http://www.marketresearchreports.biz/analysis/177969 ] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 is expected to grow at a CAGR of 10.1% from 2014 to 2020. Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related...

2014-09-01 23:01:31

The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who allegedly developed Lipitor diabetes injuries after taking the cholesterol-lowering statin drug. New York, NY (PRWEB) September 01, 2014 More than 200 Lipitor lawsuit (http://www.thelipitorlawsuit.com/) filings have been added to a federal litigation that continues to progress in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. A federal Case List published on August 15th...

2014-08-28 12:29:50

Ribbon-Cutting Ceremony Scheduled for September 3, 2014 ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD. The ceremony will mark the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China...

2014-08-26 12:30:12

DALLAS, August 26, 2014 /PRNewswire/ -- According to the new research report "Scale Inhibitor Market by Type (Phosphonates, Carboxylate/Acrylic, Sulfonates and Others), and by Application (Power & Construction, Mining, Oil & Gas, Water & Waste Water Treatment, Food & Beverage and Others) - Global Trends & Forecast to 2019", defines and segments the global scale inhibitor market with an analysis and forecast for types and applications by volume as well...

2014-08-24 23:00:47

Over the five-year period, many thin film drug manufacturers will focus on developing a drug pipeline that encompasses more therapeutic classes, such as drugs that treat respiratory-related ailments. For these reasons, industry research firm IBISWorld has updated a report on the Thin Film Drug Manufacturing industry in its growing industry report collection. New York, NY (PRWEB) August 24, 2014 Over the past five years, the Thin Film Drug Manufacturing industry has exhibited rapid revenue...

2014-08-22 23:02:33

Transparency Market Research added a new report "Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Albany, New York (PRWEB) August 22, 2014 Ophthalmic drug delivery technologies or mechanisms represent one of the interesting and challenging endeavors as the anatomy, physiology and biochemistry of the eye renders highly impervious properties to the foreign substances. Ocular drug delivery...

2014-08-20 16:25:21

LONDON, Aug. 20, 2014 /PRNewswire/ -- GlaxoSmithKline plc today announced that the FDA has approved Arnuity(TM) Ellipta(®) (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm. The approved doses are Arnuity Ellipta 100mcg and 200mcg. Arnuity Ellipta is administered once daily via the dry...

2014-08-18 23:05:04

MarketReportsOnline.com adds "Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)" report to its research store. Dallas, Texas (PRWEB) August 18, 2014 The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and Allylamines. It provides broad coverage of these classes...

2014-08-18 16:25:21

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Local Anesthetic Effect-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278631/-Local-Anesthetic-Effect-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Local Anesthetic Effect-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'